Group 1: Real Estate Industry - The core viewpoint is that the official launch of commercial real estate REITs marks a significant step towards a new development model in the real estate sector, with policies expected to accelerate the growth of C-REITs [2] - The introduction of 30 REITs-related policies by the CSRC and stock exchanges is seen as a catalyst for expanding asset classes and enhancing efficiency, which could lead to a revaluation of related assets and companies [2] - Companies deeply involved in commercial real estate and management services are expected to benefit significantly from this development [2] Group 2: Financial Services Industry - The recent guidelines from the central bank and financial regulatory authority aim to reduce the pricing cap for small loan companies, which may lead to a rapid industry cleanup [3] - The guidelines require small loan companies to stop issuing loans with comprehensive financing costs exceeding 24% immediately and to gradually lower pricing to within four times the one-year LPR by the end of 2027 [3] - The impact of these guidelines on the broader financial technology sector will depend on whether banks and consumer finance companies follow suit [3] Group 3: Transportation Industry - The outlook for January indicates a seasonal decline in passenger and cargo volumes, but there are positive signs for airline profitability and oil transportation demand [5] - The airline sector is expected to see improved revenue levels due to steady demand growth and favorable oil prices, while oil transportation rates may rise due to geopolitical tensions [5] - Recommendations include focusing on specific stocks in the airline and oil transportation sectors, as well as logistics and express delivery companies [5] Group 4: ETF Market - By the end of 2025, the total scale of ETFs in China surpassed 6 trillion yuan, with a significant increase driven by stock ETFs, which saw a 42% growth [5] - There is a notable divergence in the performance of broad-based ETFs and thematic industry ETFs, with the latter experiencing continued inflows [5] Group 5: Key Companies - Century Huatong is covered for the first time with a "buy" rating and a target price of 24.52 yuan, driven by its leadership in SLG games and strong performance in overseas markets [6] - New and emerging companies like Xinhecheng and Huaming Equipment are also highlighted for their growth potential and strategic initiatives, with target prices set at 38.24 yuan and 29.5 yuan respectively [10][12] - The report emphasizes the importance of product innovation and market expansion for companies like Sanqi Interactive Entertainment and China Jushi, which are expected to benefit from new game launches and incentive plans [8][9]

Group 1 - The Hong Kong stock market continues its "opening red" trend, with technology stocks showing active performance, particularly the Hong Kong Stock Connect Technology ETF (513860), which rose by 4.5% yesterday and continued to rebound by 1.08% today, with a trading volume exceeding 20 million HKD [1] - The ETF closely tracks the CSI Hong Kong Stock Connect Technology Index, which selects 50 large-cap, high R&D investment, and fast revenue growth technology leading companies as sample stocks. The top ten weighted stocks in the index include Alibaba-W, Tencent Holdings, SMIC, Xiaomi Group-W, and BYD Company [1] - Significant net inflow of southbound funds was recorded at approximately 18.723 billion HKD on January 5, marking the highest single-day inflow in nearly two and a half months. Over a longer period, net buying of southbound funds returned to positive, totaling 16.2 billion HKD in the week from December 15 to December 19, 2025 [1] Group 2 - Guolian Minsheng Securities commented on the Hong Kong stock market, suggesting that the continuous recovery of southbound funds is highly probable due to the strong expectations for institutional layout at the beginning of the year. The combination of domestic and foreign capital is expected to resonate under the return of profit-making effects [2] - Dongwu Securities released a report indicating that the Hong Kong stock market is "standing out" globally at the beginning of the year, and from a medium to long-term allocation perspective, the current position is attractive. The firm anticipates that southbound funds will continue to increase their allocation to Hong Kong stocks [2] - The future return of foreign capital will depend on whether there are changes in the fundamental narrative. The Hong Kong stock market is entering a period of oscillation and upward movement, and it is essential to maintain dividends as a base while seizing the technology growth opportunities in the first half of the year [2]

Core Viewpoint - Nomura forecasts that JD Health's performance in the second half of 2025 will exceed market expectations, primarily driven by a surge in flu cases in the fourth quarter, leading to increased demand for pharmaceuticals [1] Revenue Projections - Nomura estimates that JD Health's revenue in the fourth quarter of 2025 will reach 20 billion yuan, representing a year-on-year growth of 22% [1] - The growth is attributed to the pharmaceutical, nutritional, and medical device segments, which are expected to achieve year-on-year sales growth of 30%, 20%, and 10% respectively [1] Market Drivers - The spread of flu cases in the fourth quarter is expected to significantly contribute to pharmaceutical sales, accounting for a high single-digit percentage of total pharmaceutical revenue [1] - Sales of medical devices, such as home oxygen concentrators, are also anticipated to increase due to the flu outbreak [1] Marketing Strategies - Nutritional brands are expected to continue effective marketing campaigns in the fourth quarter, reinforcing their robust growth trajectory [1]

1月6日，A股三大股指早盘继续走高，沪指刷新2015年7月底以来的新高，创业板一度站上3300点，脑机接口、半导 体设备等板块继续活跃。港股同样上涨，恒指、恒科指双双涨超1%，科网股悉数拉升，京东健康涨超7%。债市方 面，国债期货全线下跌。商品方面，国内商品期货涨跌不一，金属期货继续走高，其中铂金、钯金、沪银、沪铜悉 数拉升，焦煤、焦炭下跌。核心市场走势： | 代码 | 名称 | 两日图 | 现价 | 涨跌 | 涨跌幅 | | --- | --- | --- | --- | --- | --- | | 000001 | 上证指数 | | 4058.69 | 35.27 | 0.88% | | 399001 | 深证成指 | | 13903.77 | 75.14 | 0.54% | | 399006 | 创业板指 | 14.1 | 3284.35 | -10.21 | -0.31% | | 000300 | 沪深300 | | 4759.76 | 42.01 | 0.89% | | 000016 | FiFFSO | | 3146.57 | 46.82 | 1.51% | | 000680 | 科创综 | | ...

格隆汇1月6日｜港股主要指数走高，恒生科技指数涨超2%，恒指涨超1%。科技股普涨，商汤、京东健 康涨超6%，华虹半导体涨近6%，中芯国际涨超2%。券商股拉升，国泰君安国际涨超10%，中州证券涨 超6%，中金公司涨超3%。 来源：格隆汇APP ...

记者丨黎雨桐 见习记者林健民 6日，A股三大指数高开，截至9：50左右，沪指报4054.25点，突破2025年11月14日的阶段高点，刷新 2015年7月底以来的新高。 炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ | 上证指数 深证成指 | 科创综指 | | --- | --- | | 4054.25 13946.42 | 1723.70 | | +30.83 +0.77% +117.79 +0.85% +27.86 +1.64% | | | 创业板指 万得全A | 北证50 | | 6599.79 3318.62 | 1482.88 | | +61.85 +0.95% +24.07 +0.73% +16.46 +1.12% | | | 沪深300 中证500 | 中证A500 | | 4762.71 7745.80 | 5823.89 | | +44.97 +0.95% +94.61 +1.24% +60.59 +1.05% | | | 中证1000 深证100 | 中证红利 | | 7818.17 5966.20 | 5538.87 | | +64.29 +0.83% +37 ...

Core Viewpoint - A-shares have experienced a significant rally, with the Shanghai Composite Index reaching a new high not seen since July 2015, indicating strong market sentiment and potential for continued growth in the technology sector [1][4]. Market Performance - As of the latest data, the Shanghai Composite Index is at 4054.25, up by 30.83 points (+0.77%), while the Shenzhen Component Index and the Sci-Tech Innovation Index also showed positive movements [2]. - The A-share market has achieved a remarkable 12 consecutive days of gains, marking the longest streak since 1993, with previous records being 11 consecutive days in 2006 and 2017-2018 [3]. Sector Highlights - The brain-computer interface sector is witnessing explosive growth, with companies like Xiangyu Medical and Aipeng Medical hitting the 20% daily limit up [2]. - Other notable performers include Meihua Medical, Innovation Medical, and Aerospace Changfeng, all showing significant percentage increases [3]. Future Outlook - Analysts from Dongzheng Futures and Debon Securities suggest that the current market sentiment is optimistic, with expectations for a "slow bull" market trend to continue, particularly in technology stocks [4][5]. - The report indicates that sectors such as commercial aerospace, artificial intelligence, and robotics are expected to remain in focus, alongside cyclical sectors like oil and non-ferrous metals [5]. Hong Kong Market Performance - In the Hong Kong market, tech stocks are also performing well, with JD Health rising over 6% and other companies like XPeng and NetEase seeing gains of over 3% [5][6].

Core Viewpoint - CICC has raised JD Health's revenue forecasts for 2025 and 2026 by 2% to 72.5 billion yuan and 81.7 billion yuan respectively, driven by the ongoing growth of original drug categories and strong demand for flu products [1] Group 1: Revenue Performance - The company is expected to show strong revenue growth, with a projected year-on-year increase of nearly 25% for the entire year of 2025, supported by the continuous release of original drugs and the rising demand for flu prevention since Q4 2025 [2] - In the first three quarters of 2025, the company achieved a quarterly revenue growth rate of approximately 25% year-on-year [2] Group 2: Profitability Outlook - The company's non-IFRS net profit margins for the first three quarters of 2025 were 10.6%, 9.7%, and 11.1%, showing varying degrees of improvement year-on-year, primarily due to increased advertising and marketing investments by pharmaceutical and health product companies [3] - Despite the typical increase in expenditures during Q4 2025, the company is expected to maintain a stable profit margin for the year, reflecting strong competitive capabilities [3] - The company has significant cash reserves, and potential fluctuations in interest income due to interest rate cuts may impact non-IFRS net profit in the coming quarters [3]

Group 1 - The core viewpoint is that JD Health's revenue forecasts for 2025 and 2026 have been raised by 2% to 72.5 billion and 81.7 billion respectively, driven by the strong demand for flu products and the ongoing trend of original research products [1] - The company is expected to achieve a year-on-year revenue growth of approximately 25% in 2025, with strong quarterly performance observed in the first three quarters [2] - The non-IFRS net profit for 2025 and 2026 has been adjusted upwards by 4% and 1% to 6.5 billion and 6.4 billion respectively, with a new revenue forecast for 2027 set at 91.2 billion and non-IFRS net profit at 6.8 billion [1] Group 2 - The company has shown a steady improvement in non-IFRS net profit margins, with rates of 10.6%, 9.7%, and 11.1% in the first three quarters of 2025, attributed to increased marketing investments by pharmaceutical and health product companies [3] - Despite the potential fluctuations in interest income due to cash management strategies, the overall profit performance is expected to remain robust, reflecting the company's strong competitive position [3] - The company has signed strategic cooperation agreements with major pharmaceutical firms, enhancing its business model for new drug launches [2]

Report Summary 1. Report Industry Investment Rating No information provided. 2. Core Viewpoints - On January 5, 2026, all four major stock index futures contracts for the current month rose, with IF up 2.07%, IH up 2.42%, IC up 2.81%, and IM up 2.37% [1]. - On the trading day, the total trading volume of stock index futures rebounded, indicating increased trading enthusiasm among investors. The total trading volume of IF, IH, IC, and IM increased by 20,649 lots, 6,347 lots, 29,217 lots, and 24,485 lots respectively. In terms of positions, the total positions of IF, IH, IC, and IM increased by 8,201 lots, 3,543 lots, 22,660 lots, and 13,346 lots respectively [2]. - The trend strength of IF and IH is 1, and that of IC and IM is also 1. The A - share market had a good start in 2026, with the Shanghai Composite Index rising by more than 1% and returning to 4,000 points, and the ChiNext Index surging nearly 3%. The Hong Kong stock market fluctuated slightly up, with the biotechnology and semiconductor industries strengthening [6][7]. 3. Summary by Relevant Catalogs 3.1. Stock Index Futures Data Tracking - **CSI 300 and Related Futures**: The CSI 300 closed at 4,717.8, up 1.90%. Among its futures, IF2601 closed at 4,714, up 2.07%, with a basis of - 3.75; IF2602 closed at 4,702.6, up 2.14%, with a basis of - 15.15; IF2603 closed at 4,697, up 2.26%, with a basis of - 20.75; IF2606 closed at 4,649.8, up 2.23%, with a basis of - 67.95 [1]. - **SSE 50 and Related Futures**: The SSE 50 closed at 3,099.8, up 2.26%. Among its futures, IH2601 closed at 3,097.4, up 2.42%, with a basis of - 2.35; IH2602 closed at 3,099.6, up 2.59%, with a basis of - 0.15; IH2603 closed at 3,098.8, up 2.55%, with a basis of - 0.95; IH2606 closed at 3,088.8, up 2.56%, with a basis of - 10.95 [1]. - **CSI 500 and Related Futures**: The CSI 500 closed at 7,651.2, up 2.49%. Among its futures, IC2601 closed at 7,664.8, up 2.81%, with a basis of 13.6; IC2602 closed at 7,624.8, up 2.95%, with a basis of - 26.4; IC2603 closed at 7,596, up 3.11%, with a basis of - 55.2; IC2606 closed at 7,417, up 3.27%, with a basis of - 234.2 [1]. - **CSI 1000 and Related Futures**: The CSI 1000 closed at 7,753.9, up 2.09%. Among its futures, IM2601 closed at 7,759.2, up 2.37%, with a basis of 5.32; IM2602 closed at 7,697.8, up 2.56%, with a basis of - 56.08; IM2603 closed at 7,639, up 2.69%, with a basis of - 114.9; IM2606 closed at 7,403.4, up 2.76%, with a basis of - 350.5 [1]. 3.2. Position Changes of the Top 20 Futures Members - For IF contracts, in IF2601, long positions decreased by 607 and short positions increased by 347; in IF2603, long positions increased by 5,858 and short positions increased by 5,971; in IF2606, long positions increased by 1,027 and short positions increased by 490 [5]. - For IH contracts, in IH2601, long positions decreased by 62 and short positions increased by 168; in IH2603, long positions increased by 2,259 and short positions increased by 2,443; in IH2606, long positions increased by 206 and short positions increased by 91 [5]. - For IC contracts, in IC2601, long positions increased by 598 and short positions increased by 1,459; in IC2603, long positions increased by 11,123 and short positions increased by 12,210; in IC2606, long positions increased by 2,786 and short positions increased by 2,146 [5]. - For IM contracts, in IM2601, long positions decreased by 1,660 and short positions decreased by 909; in IM2602, long positions increased by 2,233 and short positions increased by 2,659; in IM2603, long positions increased by 4,700 and short positions increased by 8,413 [5]. 3.3. Market Trends and Drivers - **A - share Market**: The A - share market had a good start in 2026. The Shanghai Composite Index rose 1.38% to 4,023.42 points, the Shenzhen Component Index rose 2.24%, the ChiNext Index rose 2.85%, the Beixin 50 rose 1.8%, the Kechuang 50 rose 4.41%, and the Wind All - A Index rose 1.99%. The total trading volume was 2.57 trillion yuan, compared with 2.07 trillion yuan the previous day [6]. - **Hong Kong Stock Market**: The Hong Kong stock market fluctuated slightly up. The Hang Seng Index rose 0.03% to 26,347.24 points, the Hang Seng Tech Index rose 0.09% to 5,741.63 points, and the Hang Seng China Enterprises Index fell 0.22% to 9,148.47 points. The market trading volume was HK$283.462 billion, significantly higher than the previous trading day's HK$140.864 billion [7]. - **US Stock Market**: The three major US stock indexes all closed up. The Dow Jones Industrial Average rose 1.23% to 48,977.18 points, reaching a new record high; the S&P 500 Index rose 0.64% to 6,902.05 points; the Nasdaq Composite Index rose 0.69% to 23,395.82 points [8].